BECN1 and obstructive sleep apnea syndrome: When treated with exosomes from different OSA patients and healthy controls at a concentration of 10 μg/ml for 24 h, the expression of LC3B II/I and beclin1 was also significantly lower in the OSA-Exos group than in the Ctrl-Exos groups (Figures 3C,D).